We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CryoCath, a maker of cryotherapy products to treat cardiovascular disease, has
announced that Vivek Reddy of the Massachusetts General Hospital presented additional
data on a human feasibility study using the company's proprietary Arctic Circler
Balloon catheter to treat atrial fibrillation (AF).
Enpath Medical has reported that the FDA requested more clinical data regarding
the company's Myopore Rx steroid lead before the agency will consider the company's
request for marketing clearance.
Corgenix Medical, due to the lack of progress toward the completion of the $6
million merger-related financing and the expiration of key dates within the
agreement and plan of merger, decided to terminate the planned merger with Genesis
Bioventures.
Sysmex announced the development of a new technology based on a cell cycle profiling for diagnosis of the risk of recurrence in patients with early-stage cancer.
Laser and light-based medical devices company Lumenis has announced an agreement
with Eclipse Medical, its distributor for aesthetic products in four states
in the South Central U.S.
Edwards Lifesciences, a maker of heart valve technologies, has entered into
an agreement with St. Jude Medical resolving patent infringement litigation
initiated by Edwards in June 2000 related to certain Edwards patents in the
areas of heart valve repair and replacement.
Molecular Diagnostics has announced it successfully completed the payments necessary
to settle their prior Internal Revenue Service (IRS) federal payroll tax liability.